PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 70 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $315,227 | +66.8% | 11,413 | -49.1% | 0.01% | +14.3% |
| Q3 2022 | $189,000 | -18.5% | 22,421 | +128.9% | 0.01% | -36.4% |
| Q1 2022 | $232,000 | -15.0% | 9,795 | -6.9% | 0.01% | -56.0% |
| Q1 2021 | $273,000 | -25.0% | 10,522 | -41.8% | 0.02% | -35.9% |
| Q4 2020 | $364,000 | +92.6% | 18,074 | +68.8% | 0.04% | +200.0% |
| Q2 2020 | $189,000 | +30.3% | 10,707 | -47.7% | 0.01% | +18.2% |
| Q1 2020 | $145,000 | +17.9% | 20,481 | +11.8% | 0.01% | +37.5% |
| Q4 2018 | $123,000 | -59.5% | 18,317 | -38.1% | 0.01% | -65.2% |
| Q3 2018 | $304,000 | +57.5% | 29,580 | +31.4% | 0.02% | +76.9% |
| Q1 2018 | $193,000 | -45.8% | 22,506 | +31.6% | 0.01% | -66.7% |
| Q4 2017 | $356,000 | – | 17,106 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |